Skip to main content
. 2014 Nov 17;9(11):e112355. doi: 10.1371/journal.pone.0112355

Table 1. Clinical characteristics of participants with and without metabolic syndrome (MS).

No MS MS p value
N 307 125
Age (years) 50.8 (12.2) 57.1 (10.2) <0.001
Gender (male (%)) 97 (31) 56 (44.8) <0.001
Systolic blood pressure (mmHg) 121 (16) 133 (15) <0.001
Diastolic blood pressure (mmHg) 77 (9) 83 (10) <0.001
Medications for hypertension (n, %) 24 (7.8) 37 (29.6) <0.001
Hypertension (n, %) 68 (22.1) 68 (54.4) <0.001
Body mass index (kg/m2) 23.1 (3.0) 26.4 (2.9) <0.001
Waist circumference (cm) 80.4 (7.3) 89.8 (7.1) <0.001
Fasting plasma glucose (mg/dL) 91.2 (10.2) 102.2 (21.2) <0.001
OGTT-2h-PG (mg/dL) 116.5 (36.2) 158.9 (71) <0.001
Hemoglobin A1c (%) 5.7 (0.4) 6.0 (1.0) <0.001
Hemoglobin A1c (mmol/mol) 39(2.7) 42(6.8) <0.001
HOMA2%B 81.6 (34.9) 87.9 (41.2) 0.1
HOMA2%S 156.8 (72.2) 108.6 (60) <0.001
Medications for diabetes (n, %) 4 (1.3) 9 (7.2) 0.003
Diabetes (n, %) 26 (8.5) 34 (27.2) <0.001
Total cholesterol (mg/dL) 193.7 (35.7) 196.4 (36.1) 0.243
Triglyceride (mg/dL) a 93.2 (62–111) 189.3 (113–209) <0.001
HDL cholesterol (mg/dL) 53.4 (10.5) 42.3 (8.2) <0.001
LDL cholesterol (mg/dL) 118.7 (31.8) 122.3 (35.8) 0.149
Medications for dyslipidemia (n, %) 4 (1.3) 16 (12.8) <0.001
Glutamate oxalate transaminase (IU/L) 23.1 (12.4) 23.6 (7.5) 0.35
Glutamate pyruvate transaminase (IU/L) 22.6 (20.7) 27.3 (16.8) 0.012
Leptin (pg/mL) a 9645 (3873–12844) 12093 (5576–15835) 0.002
Adiponectin (ng/mL) a 8040 (3678–10850) 5441 (2489–7647) <0.001
Renin (pg/mL) a 27.6 (9.3–37.3) 32.3 (10.5–40.7) 0.24
Aldosterone (pg/mL) a 48.5(22.1–61.5) 43.4 (20.3–54.1) 0.47
C-reactive protein (mg/dL) a 0.13 (0.04–0.15) 0.24 (0.06–0.24) <0.001
Subcutaneous fat (mm2) a 16588 (6935) 21203 (6769) <0.001
Peritoneal fat (mm2) a 4610 (3075) 8303 (3448) <0.001
Retroperitoneal fat (mm2) a 3629 (1925) 5927 (2154) <0.001

Means (standard deviations) are shown.

a

Medians (interquartile ranges) of variables not normally distributed are shown. Statistical analyses were performed after log transformation.

OGTT-2h-PG, plasma glucose at 2 h during oral glucose tolerance test; HOMA, homeostasis model assessment; HDL, high-density lipoprotein; LDL, low-density lipoprotein.